Park City Bio, LLC

Other

Jonathan Michael Benns

Matthew Carl Lawyer

David Allan Jones

Michael Parker Jones

A blood coagulating device can include an absorbent body; and a hemostatic lysine composition associated with the body. The body can have a cylindrical or conical member having a first end having the hemostatic composition, the first end being configured for insertion into a nasal passageway. A method for coagulating blood can include providing a powdered hemostatic lysine composition; and applying the powdered hemostatic lysine composition to blood so as to cause the blood to coagulate and form a clot. The coagulation can occur in a nasal passageway away from a blood vessel. The method can include providing at least one absorbent member having the powdered hemostatic lysine composition; and applying the at least one absorbent member to the blood so that the powdered hemostatic lysine composition causes the blood to coagulate and clot.

Lysine delivery systems for blood coagulation

A composition can include: silene extract; and a carrier having the silene extract. The composition can include an active agent, such as a pharmaceutical or a nutraceutical. The composition can be in a form of a solid, paste, gel, gum, or combination thereof. The carrier can facilitate retention in the mouth, chewing, sucking, holding in the lip next to the gums, or other non-liquid format. A method can provide an alternative to an activity that reduces desire to perform the activity, the method can include: administering to a subject in need thereof the composition having silene. The method can include administering the composition in an effective amount to treat one or more of smoking dependence, tobacco withdrawal symptoms, and tobacco dependence in the subject, wherein the activity is smoking.

Growing community of inventors

Salt Lake City, UT, United States of America

Jonathan Michael Benns